New York-based Cleerly has raised $43 million in a series B round and brought in $54 million to date. Cleerly is also one of a growing number of companies at the intersection of artificial intelligence and the cardiovascular sector.
The acquisition continues the trend of upward mobility CareDx has experienced in recent months.
The San Francisco, CA-based company has won FDA clearance for a new design and upgraded artificial intelligence for the wearable cardiac monitor.
AliveCor said in its claim that it wants to block the importation of all the Apple Watches in U.S. – and said the tech giant is infringing on three counts of ECG patents.
The launch of the MCT platform puts VitalConnect in a league of its own.